Scholarly Index
Peter G. Rose
Cleveland Clinic; 17,866 total citations; 371 total publications; best world rank #55
Cleveland Clinic
17,866Total citations
371Total publications
64H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Endometrial and Cervical Cancer Treatments | Lifetime | 73 | US 42 | 99.48 |
| Ovarian cancer diagnosis and treatment | Lifetime | 125 | US 72 | 99.34 |
| Intraperitoneal and Appendiceal Malignancies | Lifetime | 55 | US 26 | 99.08 |
| Colorectal and Anal Carcinomas | Lifetime | 173 | US 85 | 98.65 |
| Cervical Cancer and HPV Research | Lifetime | 303 | US 143 | 98.46 |
| Sarcoma Diagnosis and Treatment | Lifetime | 437 | US 219 | 98.28 |
| Uterine Myomas and Treatments | Lifetime | 232 | US 89 | 98.21 |
| PARP inhibition in cancer therapy | Lifetime | 393 | US 191 | 95.48 |
| Endometriosis Research and Treatment | Lifetime | 921 | US 282 | 95.92 |
| Chemotherapy-induced organ toxicity mitigation | Lifetime | 378 | US 100 | 88.49 |
| Chemotherapy-related skin toxicity | Lifetime | 848 | US 374 | 80.89 |
| Ovarian cancer diagnosis and treatment | 2021-2025 | 180 | US 51 | 96.99 |
| PARP inhibition in cancer therapy | 2021-2025 | 133 | US 54 | 95.41 |
| Endometrial and Cervical Cancer Treatments | 2021-2025 | 836 | US 178 | 88.76 |
| Intraperitoneal and Appendiceal Malignancies | 2021-2025 | 955 | US 230 | 69.96 |